STOCKWATCH
·
Pharmaceuticals
Quarterly Updates21 Jul 2025, 04:10 pm

Alkem Laboratories Announces 51st AGM, Reports 20.6% Y-o-Y Increase in PAT

AI Summary

Alkem Laboratories Ltd. has announced its 51st Annual General Meeting (AGM) scheduled for 25th August, 2025. The company also reported its financial highlights for the financial year 2024-2025, which include a 2.3% year-over-year increase in Revenue from Operations, a 11.9% increase in EBITDA, and a significant 20.6% increase in Profit After Tax (PAT). The company's net cash also saw a positive trend.

Key Highlights

  • Alkem Laboratories announces its 51st AGM on 25th August, 2025
  • 2.3% y-o-y increase in Revenue from Operations
  • 11.9% increase in EBITDA
  • 20.6% increase in PAT
  • Positive trend in net cash
ALKEM
Pharmaceuticals
Alkem Laboratories Ltd

Price Impact